Fig. 2From: Acceptability of neural stem cell therapy for cerebral palsy: survey of the Australian cerebral palsy communityWillingness to use accompanying procedures and participate in a clinical trial. Participants willingness to use neural stem cells (NSCs) given the need to administer them a via neurosurgery and b in conjunction with immunosuppression. c Likelihood that they would elect to enroll in a clinical trial, given the need for neurosurgery and immunosuppression as an accompanying for NSC treatmentBack to article page